Company Description
Adyton Resources Corporation develops and explores gold and copper mineral projects in Papua New Guinea. The company is an operating mining issuer focused on advancing a portfolio of mineral assets that includes the Fergusson Island gold projects and the Feni Island gold-copper project.
The company’s Papua New Guinea portfolio centers on precious-metals and copper exploration, resource definition, and project development. Its Fergusson Island Gold Projects include the Wapolu and Gameta projects. Gameta is described as a gold development project on Fergusson Island with mineral resources defined within a conceptual open-pit shell, and company updates have discussed infill drilling, high-grade gold intervals, induced polarization survey work, and follow-up drilling plans tied to resource development and target generation.
Adyton also owns the Feni Island Gold-Copper Project, where company materials describe exploration activity beyond the Kabang resource footprint. The project is positioned within the company’s broader effort to expand existing inferred and indicated mineral resources and build on prior gold and copper drill results. The company’s operating model is typical of a junior mineral exploration and development company: it deploys capital into geological surveys, drilling, resource estimation, technical studies, and project advancement rather than producing recurring commodity revenue from operating mines.
Project financing and development structures are an important part of Adyton’s business model. The Fergusson Island assets are advanced through a joint venture and earn-in structure involving East Vision International Holdings, while the company has described financing proceeds as supporting exploration activity, particularly at Feni. These arrangements connect the company’s mineral exploration work with capital formation, project-level funding, and development planning.
Adyton Resources Corporation is associated with the TSX Venture Exchange ticker ADY in its company announcements, while ADYRF represents the company’s U.S. over-the-counter quotation. The company’s public profile is defined by mineral exploration, gold and copper resource expansion, Papua New Guinea project exposure, joint venture development structures, and recurring technical updates from drilling and geophysical programs.
Stock Performance
Adyton Res (ADYRF) stock last traded at $0.2245. Over the past 12 months, the stock has gained 32.1%. At a market capitalization of $72.4M, ADYRF is classified as a micro-cap stock with approximately 311.0M shares outstanding.
Latest News
Adyton Res has 7 recent news articles, with the latest published 5 days ago. Of the recent coverage, 2 articles coincided with positive price movement and 2 with negative movement. View all ADYRF news →
SEC Filings
Financial Highlights
Upcoming Events
Updated MRE release
Wapolu operations commence
300k ROM tonnes capacity
Potential production start
RSU vesting completion
Adyton Res has 5 upcoming scheduled events. The next event, "Updated MRE release", is scheduled for July 1, 2026 (in 7 days). Investors can track these dates to stay informed about potential catalysts that may affect the ADYRF stock price.
Short Interest History
Short interest in Adyton Res (ADYRF) currently stands at 2.9 thousand shares, up 2323.3% from the previous reporting period, representing 0.0% of the shares outstanding. Over the past 12 months, short interest has increased by 32211.1%.
Days to Cover History
Days to cover for Adyton Res (ADYRF) currently stands at 4.2 days, up 322% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has increased 322% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
ADYRF Company Profile & Sector Positioning
Adyton Res (ADYRF) operates in the Other Precious Metals & Mining industry within the broader Basic Materials sector and is listed on the OTC Link.